New drug development is the core business of ENIMMUNE. Our mission is to obtain drug licenses and control sales outlets for innovative or industrially valuable new drugs or proteins and to quickly commercialize them through the division of labor. As a participant in the biotechnology industry, we operate at less risk based on an innovative business model.
Adimmune Corporation / Academia Sinica / National Health Research Institutes / National Taiwan University Hospital and Hsin-Chu Branch / China Medical University Hospital / Linkou Chang Gung Memorial Hospital / Taipei Veterans General Hospital & Taichung Veterans General Hospital / Pasteur Institute (Vietnam, HCMC) / Changhua Christian Hospital